Brown Advisory Inc Alnylam Pharmaceuticals, Inc. Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

A detailed history of Brown Advisory Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 39,123 shares of ALNY stock, worth $9.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,123

Previous 42,357 7.64%

Holding current value

$9.31 Million

Previous $10.3 Million 4.56%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$233.81 - $287.01 $756,141 - $928,190	-3,234 Reduced 7.64%	39,123 $10.8 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $448,416 - $772,863	-3,129 Reduced 6.88%	42,357 $10.3 Million
Q1 2024 Apr 24, 2024	BUY	$146.51 - $198.2 $989,968 - $1.34 Million	6,757 Added 17.45%	45,486 $6.8 Million
Q4 2023 Feb 08, 2024	BUY	$151.41 - $196.57 $532,508 - $691,336	3,517 Added 9.99%	38,729 $7.41 Million
Q3 2023 Oct 24, 2023	SELL	$170.77 - $211.65 $64,209 - $79,580	-376 Reduced 1.06%	35,212 $6.24 Million
Q2 2023 Jul 31, 2023	BUY	$185.01 - $212.05 $793,692 - $909,694	4,290 Added 13.71%	35,588 $6.76 Million
Q1 2023 May 08, 2023	SELL	$182.66 - $235.53 $94,435 - $121,769	-517 Reduced 1.63%	31,298 $6.27 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $246,198 - $320,218	-1,327 Reduced 4.0%	31,815 $7.56 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $291,626 - $488,360	-2,105 Reduced 5.97%	33,142 $6.63 Million
Q2 2022 Nov 14, 2022	SELL	$120.42 - $169.29 $886,411 - $1.25 Million	-7,361 Reduced 17.28%	35,247 $5.14 Million
Q2 2022 Aug 02, 2022	SELL	$120.42 - $169.29 $964,925 - $1.36 Million	-8,013 Reduced 19.2%	33,714 $4.92 Million
Q1 2022 Nov 14, 2022	BUY	$127.18 - $173.91 $1.13 Million - $1.55 Million	8,894 Added 26.38%	42,608 $6.96 Million
Q1 2022 May 09, 2022	BUY	$127.18 - $173.91 $1.93 Million - $2.63 Million	15,149 Added 57.0%	41,727 $6.81 Million
Q4 2021 Jan 27, 2022	BUY	$159.56 - $209.29 $4.24 Million - $5.56 Million	26,578 New	26,578 $4.51 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account

Brown Advisory Inc Alnylam Pharmaceuticals, Inc. Transaction History